The FDA has cleared Toshiba America Medical Systems to market its myocardial perfusion software, which will be available on the company's Aquilion One and Aquilion One Vision CT scanners. The technology is used to help clinicians visualize myocardial ischemia and assess whether the patient should undergo coronary blockage revascularization.

Related Summaries